849PREAL LIFE EFFICACY AND SAFETY OF AXITINIB (AXI) IN PATIENTS WITH RENAL CELL CARCINOMA (RCC): RESULTS FROM THE SPANISH COMPASSIONATE USE PROGRAM
Maroto, P., Lainez, N., Esteban, E., Espinosa, M., Juan, M.J., Etxaniz, O., Suarez, C., Sepúlveda, J.M., Rubio, G., Arija, J.A. Arranz, Jimenez, L., Saez, M.I., Puente, J., Gonzalez, I. Chirivella, GaVolume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu337.42
Date:
September, 2014
File:
PDF, 69 KB
2014